Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer

Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer

IntroductionIdentification of effective therapies for colorectal cancer (CRC) remains an urgent medical need, especially for the microsatellite stable (MSS) phenotype. In our previous study, potassium oxonate (PO), a uricase inhibitor commonly used for elevating uric acid in mice, unexpectedly showe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuanyuan Wang, Chenxi Hu, Tianpeng Du, Jiawen Li, Kaiyuan Hui, Xiaodong Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	anti-PD-1 CRC immunotherapy immune microenvironment potassium oxonate
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1528004/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01)

Intake of sodium and potassium, sodium-potassium intake ratio, and their relation to the risk of diabetes mellitus
by: Sung Keun Park, et al.
Published: (2025-02-01)

Enhancing counterfeit RFID tag classification through distance based cognitive risk control
by: Haifeng Wu, et al.
Published: (2025-02-01)

Potassium Deficiency in Cotton: Causes, Symptoms, and Considerations
by: Kulpreet Singh, et al.
Published: (2024-02-01)

Resetting the Hsc70-mediated lysosomal degradation of PD-L1 via a supramolecular meso peptide for the restoration of acquired anti-tumor T cell immunity
by: Yujia Zhao, et al.
Published: (2025-02-01)

Potassium Fertilizer Recommendations for Sugarcane on Florida Organic Soils
by: James Mabry McCray
Published: (2019-02-01)

Potassium Fertilizer Recommendations for Sugarcane on Florida Organic Soils
by: James Mabry McCray
Published: (2019-02-01)

Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)

Chronic Kidney Disease: Potassium and Your Diet
by: Ashley R. Kendall, et al.
Published: (2016-11-01)

Chronic Kidney Disease: Potassium and Your Diet
by: Ashley R. Kendall, et al.
Published: (2016-11-01)

Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
by: Preston Ngo, et al.
Published: (2025-02-01)

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)

The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
by: Jie Hu, et al.
Published: (2024-09-01)

Potassium Adsorption Phenomenon in Calcareous Soils of Shahrazur Plain
by: Kamil Sabir Saeed
Published: (2021-07-01)

Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01)

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients
by: Amalia Azzariti, et al.
Published: (2025-02-01)

Tracking Local and Regional Influences of Potassium at the Korean Peninsula under Asian Continental Outflows during Spring
by: Jinsang Jung, et al.
Published: (2022-11-01)

Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial
by: Jiamin Yu, et al.
Published: (2025-02-01)

NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
by: Ismail M Meraz, et al.
Published: (2025-02-01)

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01)

Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
by: Hidekazu Hirano, et al.
Published: (2025-02-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
by: Dandan Yuan, et al.
Published: (2025-12-01)

Effects of Brackish Water with Different Sodium-Potassium Ratios on Soil Water-Salt Characteristics and Winter Wheat Growth
by: GAO Weiqiang, et al.
Published: (2024-12-01)

Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
by: Jingfang Wang, et al.
Published: (2025-02-01)

A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment
by: Zixuan Xiong, et al.
Published: (2025-02-01)

CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
by: Sara W. Feigelson, et al.
Published: (2025-02-01)

Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
by: Jesse Haramati, et al.
Published: (2025-02-01)

Day before late regimen vs standard split dose of low-volume PEG-CS for early morning colonoscopy: Multicenter randomized controlled trial
by: Luigi Pasquale, et al.
Published: (2025-01-01)

Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico
by: Waqas Safir, et al.
Published: (2025-02-01)

Editorial: Immunity and pulmonary vascular diseases: challenges, advances and future perspectives
by: Qi Jin, et al.
Published: (2025-02-01)

Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer
by: Yi Xie, et al.
Published: (2025-02-01)

Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer
by: Ying Ding, et al.
Published: (2025-02-01)

Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma
by: Yuli Jian, et al.
Published: (2025-02-01)

Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered
by: Pengfei Chen, et al.
Published: (2025-03-01)

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy
by: Meifeng Luo, et al.
Published: (2025-02-01)

Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation
by: Yuanchao Shi, et al.
Published: (2025-02-01)